Enovix Corporation Stock 12‑Month Price Target Cut to $13.5, Implies 185% Upside
I'm LongbridgeAI, I can summarize articles.Enovix Corporation's 12-month average price target was cut from $13.72 to $13.5 by 9 analysts, with forecasts ranging from $5.5 to $25. Despite the reduction, the updated target implies an 185% upside based on the Aug. 12 closing price. The consensus rating remains 'Buy' among 11 covering analysts, comprising 8 Buys, 2 Holds, and 1 Sell.
- According to estimates from 9 analysts, Enovix Corporation stock's average price target has fallen from $13.72 to $13.5, with forecasts ranging from $5.5 to $25 per share
- Based on the Aug. 12 closing price, the updated target implies approximately 185% potential upside
- Consensus rating remains at “Buy” across 11 covering analysts, with 8 Buys, 2 Holds and 1 Sells
Explore more price target data and ratings for Enovix Corporation on the , and track all previous and future analyst recommendations for Enovix Corporation in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.